ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07669
0,08%
Bitcoin
64.419,41
0,66%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. VolitionRX Limited (VNRX)

  7. VolitionRX Limited (VNRX) News

VNRX VolitionRX Limited

0,9499
0,0716 (8,15%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
VolitionRX Limited VNRX AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,0716 8,15% 0,9499 01:40:40
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,8739 0,845 0,9149 0,8909 0,8783
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
23.4.202414:00PRNUSNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe..
26.3.202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
25.3.202421:10PRNUSVolitionRx Limited Announces Full Fiscal Year 2023 Financial..
21.3.202413:30PRNUSVolitionRx Limited Schedules Fourth Quarter and Full Year..
20.3.202413:30PRNUSVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer..
19.3.202421:30PRNUSVolition appoints Dr Andrew Retter as Chief Medical Officer
14.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202421:56EDGAR2Form SC 13D/A - General statement of acquisition of..
02.2.202414:00PRNUSVolition to Share Nu.Q® NETs Strategy Update at Upcoming..
26.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202414:00PRNUSVolition Issues Business Review 2023
03.1.202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202414:00EDGAR2Form 8-K - Current report
20.12.202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202314:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202314:07EDGAR2Form 8-K - Current report
05.12.202314:00PRNUSVolitionRx Secures Approximately $5.5 Million in Belgium..
28.11.202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.11.202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.11.202322:10PRNUSVolitionRx Limited Announces Third Quarter 2023 Financial..
08.11.202314:00PRNUSVolitionRx Limited Schedules Third Quarter 2023 Earnings..
06.11.202312:24PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
06.11.202312:21PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
23.10.202314:00PRNUSVolition Presents Breakthrough Liquid Biopsy Blood Test..
20.10.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

AMEX
VNRX
VolitionRX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten